The Brain Tumor Research Program at MD Anderson Cancer Center offers robust training in brain tumor research through its two-year Training in Brain Tumor Research Seminars. This program opens its doors to national and international scientists alike, spanning various levels of education, from summer students (high school and college), to graduate students and postdoctoral fellows.
Besides the innovative and translational research opportunities that MD Anderson provides its research trainees, the Training in Brain Tumor Research Seminars educational course offers weekly one-hour training lectures based on two components:
- Top lectures in brain tumors from experts in fundamentals and trending topics in brain tumors, such as clinical aspects, neurodevelopment and neuropsychology. These lectures are informative and encourage our trainees to continue moving towards our common goal.
- Presentations from the trainees' current projects or published data. Allowing trainees to present in front of their peers and mentors assists with the development of professional communication skills and establishment of networking. Trainees receive constructive criticism pre-presentation as well as during their seminar. This platform has been used, for example, as an opportunity to rehearse Ph.D. thesis defenses by trainees.
The Training in Brain Tumor Research Seminars have an average audience of 50 people from different areas of research, such as Neuro-Oncology, Neurosurgery, Neuropsychology, Pathology, Radiation Oncology, Pediatrics and Melanoma.
Caroline Ross Endowed Fellowship
The Caroline Ross Endowed Fellowship award supports and develops the next generation of brain tumor researchers. Recent recipients are shown below.
2018 Caroline Ross Endowed Fellowship Recipients
- Ze-yan Zhang, postdoctoral fellow in Radiation Oncology - Research (PI: Erik Sulman)
Development of a CRISPR-Cas9D10A targetable, highcomplexity, single-cell barcoding approach for isolation of treatment resistant subclones from heterogeneous malignant gliomas
- Qianghu Wang, postdoctoral fellow in Genomic Medicine (PI: Erik Sulman)
Deciphering glioma intrinsic transcriptional subtypes identifies tumor evolution associates with changes in immune-microenvironment
- Teresa T. Nguyen, graduate research assistant - GSBS, in Neuro-Oncology - Research (PI: Juan Fueyo-Margareto)
Treatment of brain tumors in mice utilizing Delta-24-RGDOX and IDO inhibitors induces durable and longterm survival
- Jie Yang, graduate research assistant - GSBS, in Radiation Oncology - Research (PI: Erik Sulman)
Accurate detection of TERT promoter mutation and ATRX mutation in gliomas using Infinium DNA methylation arrays identifies novel epigenetic association
- Alessandra Audia, postdoctoral fellow in Translational Molecular Pathology (PI: Krishna Bhat)
Directed neuronal differentiation in GBM by suppression of TAZ
- Grant M. Fischer, graduate research assistant - GSBS, in Melanoma Medical Oncology - Research (PI: Michael Davies)
Molecular Profiling Implicates Oxidative Phosphorylation as a Targetable Metabolic Strategy in Melanoma Brain Metastases
- Soon Young Park, postdoctoral fellow in Neuro-Oncology - Research (PI: John de Groot)
CLK2 is a key regulator of the cell cycle through FOXO3a/p27 in glioma models
- Jie Ding, postdoctoral fellow in Neuro-Oncology - Research (PIs: Alfred Yung and Dimpy Koul)
Amplified EGFR drives tumorigenesis in TP53 wild type glioblastoma through inhibition of p53 function by DNA-PK/p53 binding